Table 2.
Treatments for AKI in ECMO
Treatment | Pros | Cons |
---|---|---|
IHD | Potentially joinable with the main ECMO circuit | Rapid fluid removal and hemodynamic instability |
Reduced downtime | Disequilibrium syndrome and potential risk of cerebral edema | |
Lower costs than CRRT | Technically more complex and demanding | |
Prolonged IHD | Potentially joinable with the main ECMO circuit | Potentially associated with hypotension in high-risk patients |
Slower volume and solute removal than IHD | Technically more complex and demanding | |
Reduced downtime and costs compared with CRRT | ||
CRRT | Potentially joinable with the main ECMO circuit | Patient immobilization Increased risk of hypothermia High costs |
Continuous removal of toxins Hemodynamic stability Tight and easy control of fluid balance Gentle solute removal avoiding disequilibrium syndrome Potentially allows blood purification therapies for systemic inflammation | ||
Potentially allows blood purification therapies for systemic inflammation | ||
PD | Hemodynamic stability | Mainly restricted to the pediatric population and to patients already treated with chronic PD |
Technically simple | Requires specific intraperitoneal catheters Risk of peritonitis | |
Lower cost | Impairs diaphragmatic movements, potentially prolonging the weaning from ECMO |
IHD = Intermittent hemodialysis; PD = peritoneal dialysis.